167 related articles for article (PubMed ID: 31226663)
1. Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness.
Tomkowski WZ; Davidson BL
Thromb Res; 2019 Aug; 180():62-63. PubMed ID: 31226663
[No Abstract] [Full Text] [Related]
2. Rivaroxaban with or without aspirin for prevention of cardiovascular disease.
Kruger PC; Eikelboom JW; Yusuf S
Coron Artery Dis; 2018 Aug; 29(5):361-365. PubMed ID: 29346127
[No Abstract] [Full Text] [Related]
3. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Spyropoulos AC; Ageno W; Albers GW; Elliott CG; Halperin JL; Hiatt WR; Maynard GA; Steg PG; Weitz JI; Suh E; Spiro TE; Barnathan ES; Raskob GE;
N Engl J Med; 2018 Sep; 379(12):1118-1127. PubMed ID: 30145946
[TBL] [Abstract][Full Text] [Related]
4. Adding rivaroxaban to aspirin after CABG surgery.
Lim GB
Nat Rev Cardiol; 2019 Mar; 16(3):133. PubMed ID: 30692655
[No Abstract] [Full Text] [Related]
5. Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
Pogosova N; Bosch J; Bhatt DL; Fox KAA; Connolly SJ; Alings M; Verhamme P; Muehlhofer E; Shestakovska O; Yusuf S; Eikelboom JW
Circulation; 2022 Jun; 145(25):1875-1877. PubMed ID: 35728054
[No Abstract] [Full Text] [Related]
6. Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study.
Yuenyongviwat V; Tuntarattanapong P; Chuaychoosakoon C; Iemsaengchairat C; Iamthanaporn K; Hongnaparak T
Eur J Orthop Surg Traumatol; 2019 May; 29(4):877-881. PubMed ID: 30627921
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thromboembolism according to baseline risk factor profiles.
Prins MH; Lensing AWA; Prandoni P; Wells PS; Verhamme P; Beyer-Westendorf J; Bauersachs R; Bounameaux H; Brighton TA; Cohen AT; Davidson BL; Decousus H; Kakkar AK; van Bellen B; Pap AF; Homering M; Tamm M; Weitz JI
Blood Adv; 2018 Apr; 2(7):788-796. PubMed ID: 29632234
[TBL] [Abstract][Full Text] [Related]
8. Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
Kerr DL; Butler S; Read AC; Harris IA
ANZ J Surg; 2019 Oct; 89(10):1211-1216. PubMed ID: 31234237
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban versus Aspirin in Prevention of Venous Thromboembolism: A Meta-Analysis of 9 Randomized Controlled Trials comprising 7,656 Patients.
Xie J; Jiang M; Lin Y; Deng H; Xie X; Li L
Thromb Haemost; 2019 Sep; 119(9):1517-1526. PubMed ID: 31365943
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study.
Camporese G; Bernardi E; Noventa F; Bosco M; Monteleone G; Santoro L; Bortoluzzi C; Freguja S; Nardin M; Marullo M; Zanon G; Mazzola C; Damiani G; Maniscalco P; Imberti D; Lodigiani C; Becattini C; Tonello C; Agnelli G;
Thromb Haemost; 2016 Aug; 116(2):349-55. PubMed ID: 27075710
[TBL] [Abstract][Full Text] [Related]
11. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
[TBL] [Abstract][Full Text] [Related]
12. Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS.
Bhagirath VC; Eikelboom JW; Anand SS
Future Cardiol; 2018 Nov; 14(6):443-453. PubMed ID: 30417662
[TBL] [Abstract][Full Text] [Related]
13. VOYAGER PAD contributes to medical therapy for peripheral artery disease.
Farber A
J Vasc Surg; 2020 Dec; 72(6):1843-1844. PubMed ID: 33222822
[No Abstract] [Full Text] [Related]
14. [The EINSTEIN CHOICE study].
Agnelli G; Becattini C; Giustozzi M; Imberti D; Benedetti R; Fontana M
G Ital Cardiol (Rome); 2017 Sep; 18(9):613-617. PubMed ID: 28845870
[No Abstract] [Full Text] [Related]
15. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
[TBL] [Abstract][Full Text] [Related]
16. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
[No Abstract] [Full Text] [Related]
17. Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
Prandoni P; Lensing AWA; Prins MH; Gebel M; Pap AF; Homering M; Bauersachs R; Beyer-Westendorf J; Bounameaux H; Cohen AT; Davidson BL; van Bellen B; Verhamme P; Wells PS; Yuan Z; Levitan B; Weitz JI
Thromb Res; 2018 Aug; 168():121-129. PubMed ID: 30064683
[TBL] [Abstract][Full Text] [Related]
18. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
Gibler WB
Crit Pathw Cardiol; 2018 Jun; 17(2):53-68. PubMed ID: 29768312
[No Abstract] [Full Text] [Related]
20. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
